Navigation Links
MannKind to Present at the Cowen and Company Healthcare Conference
Date:3/13/2008

VALENCIA, Calif., March 13 /PRNewswire-FirstCall/ -- MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at the Cowen and Company Healthcare Conference on March 17, 2008 at 3:15 PM ET at the Marriott Copley Place Hotel in Boston, MA.

Interested parties can access a link to the live web cast of the presentation in the Investor Relations section of the Company's website at http://www.mannkindcorp.com. A replay of the presentation will be available for 14 days.

About MannKind Corporation

MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer. Its lead product, the Technosphere(R) Insulin System, is currently in phase 3 clinical trials in the United States, Europe and Latin America to study its safety and efficacy in the treatment of diabetes. For more information on MannKind Corporation and its technology, visit http://www.mannkindcorp.com.


'/>"/>
SOURCE MannKind Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. MannKind Corporation Reports Fourth Quarter and Full Year 2007 Financial Results
2. MannKind Corporation Reports Third Quarter Financial Results
3. MannKind to Present at Upcoming Conferences
4. MannKind Announces New $350 Million Credit Facility
5. Brookdale to Present at Lehman Global Healthcare Conference on March 19
6. Jazz Pharmaceuticals, Inc. Announces LUVOX CR Launch Plans and Reports Development Pipeline Progress at Investor Day Presentation
7. SURGEX(TM) Joins the Team of Sponsors for the PGA Tours 2008 Arnold Palmer Invitational Presented by MasterCard
8. HealthSouth to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference and the 2008 Credit Suisse Global Leveraged Finance Conference
9. Wellness Initiative for 2008 Tour de Georgia Presented by AT&T Led by New Partnership With Blue Cross and Blue Shield of Georgia
10. Sunesis Pharmaceuticals to Present at Healthcare Investor Conferences in March
11. Medivation to Present at Cowen and Companys 28th Annual Health Care Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... plagued by neurological symptoms, study finds ,... Neurological side effects are among the potential...ar cancer who were treated with cisplatin-based ch...included 1,409 Norwegian men treated for unilatera... part in a follow-up survey conducted from 1998 to...
(Date:11/25/2009)...eImprovementShownforthe4thStraightYear ,, WAS...gCancerAlliance-Georgia(LCA-GA)issuedthe 4thAnnual...progressbeingmadeagainstthislethaldiseaseinthestat...A),theonlynationalorganizationdedicatedexclusively...riskforlungcancer. ,, (Logo: http://www.newscom...
(Date:11/25/2009)...placed under the skin kill tumor cells, study find...) -- A cancer vaccine delivered in a fingernail-si...ew study reports. , The method uses polymer dis...ith tumor-specific antigens and implanted under th...mors. The Harvard University scientists who develo...
(Date:11/25/2009)... BioSpace.com, the premier resource for ... third edition of the BioForest™ Hotbed Camp...ewood, CO (Vocus) November 25, 2009 -- BioSpace.co...nd information, unveiled the third edition of the ..., , ,This regional campaign is a promotional effo...
(Date:11/25/2009)...ECITY,Nov.25/PRNewswire/--dazzlesmile,llc www.dazz...lhealthscience.com havefileda67-pagefederallawsuit...Inc.,JesseWillms,FarendServicesLimited,andAtLastFu...tatesDistrictCourtfortheDistrictofUtah,allegesmass...le(TM)brandedteethwhiteningproducts,violationsofth...
Breaking Medicine News(10 mins):Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2Health News:BioSpace Showcases Leading Life-Science Companies in the Northwest 2Health News:dazzlesmile Sues Epic Advertising and Jesse Willms 2
...plements of a fatty acid found in fish oil halves .... Previous research has found that eating oily fis... sudden cardiac death caused by a particular type ...ents. The study found that 1 gram daily of p...
... to a new study shows that women with a specific ...olesterol when they take oestrogen.// Previous res...RT) might protect women from heart disease. Now do...00 women with heart problems who took HRT or place...
...lian psychiatrist has discovered that treating pat...delusions and halucinations.// Although antipsycho... many people still suffer these. But resea...en and it usually strikes them later in life. Stu...
... to study in University of Texas, a novel blood te...sting a possible new way to predict who might get ...edicine in St. Louis said it is unclear whether a ... cause of Alzheimer's. Some people have a genetic ...
...and Drug Administration announced that Vioxx - Mer...ormation on its label. The FDA said that Merck can...ications// than one older non-steroidal anti-infla...h blood pressure. Manufacturer Merck & Compan...
... to researchers at the Mayo Clinic, promote a simp...deal with stress. Hypnotherapy can be a great way ...and relieve pain. Its success depends upon why it ...enefit from a simple form of self hypnosis. ...
Other Medicine News:Health News:Blood test may aid foretell Alzheimer's 2
(Date:11/25/2009)...swire/--RemediumTechnologiesInc.,acompanydevelopin...firstprizeand$10,000intheMostPromisingSecurityIdea...ficialsannouncetoday. ,, Selectedfrommorethan10...eirinventionattheGSCSecuritySummitconferenceheldat...ediumtechnologies.com )isdevelopingahigh-pressuref...
(Date:11/25/2009)...stCall/--ChinaSkyOne,Medical,Inc.("ChinaSkyOneMedi...ntegratedpharmaceuticalcompanydevelopingandproduci...na("PRC"),today,announcedthattheCompanyrecentlypas...maceuticalandBiologicalProducts("ICPBP")examinatio...rostateSpecific,Antigen(ColloidalGold)anditsDeterm...
(Date:11/25/2009)...tCall/--Abaxis,Inc.(Nasdaq: ABAX ),amedicalproduct...tems,announcedtodaythatClintSeverson,chairmanandch...rJaffrayHealthCareConferenceonWednesday,December2,...rkPalaceHotelinNewYorkCity. ,, AboutAbaxis ,...loodanalysissystemsforuseinanyveterinaryorhumanpat...
Breaking Medicine Technology:Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3According to Excel Physical Therapy and Fitness Awareness Still Low for Law that Allows People to go Directly to a Physical Therapist without a Docto 58347 1According to Excel Physical Therapy and Fitness Awareness Still Low for Law that Allows People to go Directly to a Physical Therapist without a Docto 58347 2According to Excel Physical Therapy and Fitness Awareness Still Low for Law that Allows People to go Directly to a Physical Therapist without a Docto 58347 3Does Helicobacter pylori eradication therapy prevent gastric cancer 3F 58344 1Does Helicobacter pylori eradication therapy prevent gastric cancer 3F 58344 2Environmental health chief in Milwaukee to hear citizen concerns 10107 1Environmental health chief in Milwaukee to hear citizen concerns 10107 2
... Primary Efficacy Endpoint Met in Stage 1 of Two-S...- 100% of Evaluable Patients to Date Continue to S...or Stable Disease -, TUSTIN, Calif., July 2 Pere... reported that its lead product,candidate bavituxi...point,in its ongoing Phase II clinical trial in pa...
...s show promise for ,buying time, in victims of let...TTLE, July 1 For the first time, researchers have...ounts of inhaled or,intravenous hydrogen sulfide, ...r sulfurous stench -- significantly improves survi...ist Mark B. Roth, Ph.D., and colleagues in the Bas...
Other Medicine Technology:Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer 2Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer 3Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer 4'Hibernation-On-Demand' Drug Hydrogen Sulfide Significantly Improves Survival After Extreme Blood Loss 2'Hibernation-On-Demand' Drug Hydrogen Sulfide Significantly Improves Survival After Extreme Blood Loss 3
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
Medicine Products: